NO20040029L - Fremgangsmåte for fremstillingen av zaleplon - Google Patents

Fremgangsmåte for fremstillingen av zaleplon

Info

Publication number
NO20040029L
NO20040029L NO20040029A NO20040029A NO20040029L NO 20040029 L NO20040029 L NO 20040029L NO 20040029 A NO20040029 A NO 20040029A NO 20040029 A NO20040029 A NO 20040029A NO 20040029 L NO20040029 L NO 20040029L
Authority
NO
Norway
Prior art keywords
zaleplon
preparation
ethyl
reaction
formic acid
Prior art date
Application number
NO20040029A
Other languages
English (en)
Inventor
Monika Korycinska
Tomasz Stawinsky
Maciej Wieczorek
Original Assignee
Adamed Sp Zoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Sp Zoo filed Critical Adamed Sp Zoo
Publication of NO20040029L publication Critical patent/NO20040029L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20040029A 2002-05-14 2004-01-05 Fremgangsmåte for fremstillingen av zaleplon NO20040029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL353870A PL207322B1 (pl) 2002-05-14 2002-05-14 Sposób wytwarzania zaleplonu
PCT/PL2003/000043 WO2003095456A1 (en) 2002-05-14 2003-05-12 A process for the preparation of zaleplon

Publications (1)

Publication Number Publication Date
NO20040029L true NO20040029L (no) 2004-01-05

Family

ID=29417606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040029A NO20040029L (no) 2002-05-14 2004-01-05 Fremgangsmåte for fremstillingen av zaleplon

Country Status (13)

Country Link
US (1) US7057041B2 (no)
EP (1) EP1506199B1 (no)
AT (1) ATE342903T1 (no)
AU (1) AU2003243061A1 (no)
BR (1) BR0304837A (no)
CA (1) CA2482545A1 (no)
DE (1) DE60309159D1 (no)
ES (1) ES2275110T3 (no)
NO (1) NO20040029L (no)
PL (1) PL207322B1 (no)
RU (1) RU2004136843A (no)
UA (1) UA77292C2 (no)
WO (1) WO2003095456A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100828A2 (en) * 2001-06-12 2002-12-19 Biogal Gyogyszergyar Rt Process for the production of zaleplon
US6852858B2 (en) 2001-08-01 2005-02-08 Biogal Gyogyszergyar Rt. Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
HUP0400325A3 (en) * 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
US9618162B2 (en) 2014-04-25 2017-04-11 Cree, Inc. LED lamp

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
WO2002100828A2 (en) * 2001-06-12 2002-12-19 Biogal Gyogyszergyar Rt Process for the production of zaleplon

Also Published As

Publication number Publication date
WO2003095456A1 (en) 2003-11-20
AU2003243061A1 (en) 2003-11-11
EP1506199A1 (en) 2005-02-16
PL207322B1 (pl) 2010-11-30
DE60309159D1 (de) 2006-11-30
EP1506199B1 (en) 2006-10-18
US20050234237A1 (en) 2005-10-20
ATE342903T1 (de) 2006-11-15
ES2275110T3 (es) 2007-06-01
US7057041B2 (en) 2006-06-06
PL353870A1 (en) 2003-11-17
CA2482545A1 (en) 2003-11-20
RU2004136843A (ru) 2005-07-20
UA77292C2 (uk) 2006-11-15
BR0304837A (pt) 2004-08-17

Similar Documents

Publication Publication Date Title
MX337817B (es) Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
CY1112253T1 (el) Ενωσεις διαμινοτριαζολιου χρησιμες ως αναστολεις κινασης πρωτεϊνης
HRP20020585B1 (hr) 2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
NO20071967L (no) Imidazo-benzodiazepinderivater
SI1711481T2 (sl) Postopek za pripravo 2-aminotiazoli-5-aromatiäśnih karboksamidov kot kinazni inhibitorji
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
HRP20050711A2 (en) NITROGEN-SUBSTITUTED HEXAHYDROPYRAZINO[1,2-a]PYRIMIDINE-4,7-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS
WO2005076990A3 (en) Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
EA200802054A1 (ru) Ингибиторы фермента
WO2003106416A3 (en) CHEMICAL PROCESS
ATE502036T1 (de) Als inhibitoren von beta-sekretase (bace) geeignete 2-amino-3,4-dihydropyridoä3,4- düpyrimidinderivate
CY1110711T1 (el) Παραγωγα πυραζολο [3,4-d]αζεπινης ως ανταγωνιστες ισταμινης η3
MX2007004640A (es) Derivados de benzodiazepina sustituidos con halogeno.
TR200402588T3 (tr) N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi
NO20040029L (no) Fremgangsmåte for fremstillingen av zaleplon
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
EP1241170A3 (en) Pyrazolopyrimidine derivatives
DE50209165D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder salze als zusatz zu tierfuttermitteln
ATE368667T1 (de) Verfahren zur herstellung von n-ethyl-n-(3-(3- cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)- acetamid
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
DE60332874D1 (de) Pyren-gebundene pyrrolo(2,1-c)(1,4)benzodiazepin-derivate zur verwendung als antikrebsmittel
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
WO2008068600A3 (en) An improved process for the preparation of zaleplo